drug

RTX-015

Phase 3updated 3mo ago

by Ray Therapeutics Inc

Phase 3

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying RTX-015

phase1Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION)active not recruitingn=10

News(1)

Fierce Biotech Fundraising Tracker '26: Vaderis nets $152M series B; Epicrispr adds $90M
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.
fiercebiotech · 7mo ago

Data sources

ClinicalTrials.gov

last refreshed 26m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

RTX-015

Phase 3updated 3mo ago

by Ray Therapeutics Inc

Phase 3

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying RTX-015

phase1Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION)active not recruitingn=10

News(1)

Fierce Biotech Fundraising Tracker '26: Vaderis nets $152M series B; Epicrispr adds $90M
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.
fiercebiotech · 7mo ago

Data sources

ClinicalTrials.gov

last refreshed 26m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

RTX-015

all catalysts(0)

Trials studying RTX-015

News(1)

Report a data issue

comments(0)

RTX-015

all catalysts(0)

Trials studying RTX-015

News(1)

Report a data issue

comments(0)